A new program at The Moncton Hospital to provide patient treatment for those with Parkinson’s disease and other movement disorders.
Deep brain stimulation involves implanting a device in the brain. It sends electrical impulses that can alleviate symptoms and help relieve various neurological disorders.
“Equipped with this advanced technology, Moncton will be recognized as a leading centre for Parkinson’s disease treatment for New Brunswickers and Prince Edward Islanders,” said Greg King, the foundation’s president and CEO.
“Our donors significantly enhance patient care, and community support is more crucial than ever to advance our healthcare services and help people live their best lives.”
The Friends of the Moncton Hospital Foundation provided equipment costs of $250,000. The Department of Health is providing $394,000 for annual operational funding.
The equipment will be used this month for the first time during a procedure performed by neurosurgeon Dr. Antonios El Helou.
Parkinson’s disease is a neurodegenerative condition that typically develops after the age of 55.
